Viewing StudyNCT00468728



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00468728
Status: COMPLETED
Last Update Posted: 2017-04-21
First Post: 2007-05-01

Brief Title: PAR-101OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea CDAD
Sponsor: Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization: Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-10-04
Start Date Type: ACTUAL
Primary Completion Date: 2009-12-11
Primary Completion Date Type: ACTUAL
Completion Date: 2009-12-11
Completion Date Type: ACTUAL
First Submit Date: 2007-05-01
First Submit QC Date: May 1 2007
Study First Post Date: 2007-05-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-07-29
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2010-08-27
Disp First Submit QC Date: August 27 2010
Disp First Post Date: 2010-08-31
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-03-23
Last Update Post Date: 2017-04-21
Last Update Post Date Type: ACTUAL